[Clinicoimmunological disorders in patients with chronic prostatitis caused by latent urogenital infection].
The study enrolled 506 males 20 to 50 years of age (mead age 30.8 +/- 0.5 years) with chronic prostatitis (CP). Group 1 consisted of 332 (65 +/- 4.1) patients with CP caused by lateral urogenital infection (LUGI) due to chlamydias, ureaplasmas, mycoplasmas, gardnerellas, herpes virus type 2. Group 2 comprised 174 patients free of LUGI. T-cell and humoral immunity parameters were assessed by T-lymphocytes CD3, T-helpers CD4, T-suppressors CD8, CD4/CD8, natural killer cells CD16 using indirect immunofluorescence. Phagocytic activity of T-lymphocytes was estimated with latex as the antigen. An etiological factor was ureaplasmas, chlamydias and others in 170 (51.2 +/- 5.4%) and 155 (46.7 +/- 5.4%) patients, respectively. Mixed infection was diagnosed in 94 (28.3 +/- 4.8%) patients. Secondary immune and interferon deficiencies were detected in 155 (30.6%) patients of both groups. The patients received etiological (antimicrobial) and pathogenetic (immunological) therapy. The highest effect was obtained in prostatitis caused by mono-LUGI. Pain and pollakiuria attenuated, the copulative function improved. The conclusion is made that CP, especially secondary to LUGI, should be treated by combination of etiotropic with immunotropic methods.
Kalinina
S N
SN
Tiktinskiĭ
O L
OL
Aleksandrov
V P
VP
D000328:Adult; D015703:Antigens, CD / Q000032:analysis; D002908:Chronic Disease; D003131:Combined Modality Therapy; D006801:Humans; D007167:Immunotherapy; D007372:Interferons / Q000097:blood / Q000172:deficiency; D008297:Male; D008875:Middle Aged; D010587:Phagocytosis; D011472:Prostatitis / Q000276:immunology* / Q000382:microbiology / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology; D014552:Urinary Tract Infections / Q000150:complications*
D015703:Antigens, CD; D007372:Interferons